Structural Formula (Figure 1 Structure)
Oxybutynin Chloride Tablet
Product Images NDC 68788-8141
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 68788-8141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Table 1 (Figure 2 Table1)
This appears to be a table showing the values of different parameters (G, Toa, AUC, UGy) for two different types of butynin - R-Oybutynin and S-Ouybutynin - measured in different units (ng/ml, 1, ng=h/mL, and ngehiml). Without further context or information, it is difficult to determine the purpose of these measurements or what they represent.*
Figure 1 (Figure 3 Figure1)
Table 2 (Figure 4 Table2)
Figure 2 (Figure 5 Figure2)
Table 3 (Figure 6 Table3)
This is a report on the adverse events associated with the drug Oxybutynin Chloride. The report includes different body system disorders and the percentage occurrences of these adverse events in patients. The following adverse events with their corresponding percentages were listed: Urinary tract infection 65%, Insomnia 55%, Nervousness 65%, Dizziness 166%, Somnolence 140%, Headache 5%, Blurred vision 96%, Dry mouth 714%, Constipation 151%, Nausea 116%, and Dyspepsia 60%, Urinary Hesitation 85%, Urinary Retention 6.0%.*
Kvk Logo (Figure 7 Company Logo)
Oxybutynin Chloride Tablets Usp 5mg (Figure 8 100s Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
